Quantcast

Latest Clinical trial Stories

2014-09-15 08:29:32

- Significantly Improved Agitation in 220-Patient 10-week Study - ALISO VIEJO, Calif., Sept. 15, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced positive results from its phase II clinical trial evaluating the safety and efficacy of AVP-923 for the treatment of agitation in patients with Alzheimer's disease. Treatment with AVP-923 was associated with significantly reduced agitation as measured by the primary endpoint, the agitation/aggression...

2014-09-15 08:29:28

Company CEO to present on September 17, 2014 JERUSALEM, September 15, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the Company's CEO, Nadav Kidron will present at DC Finance's Family Office & Wealth Management Annual Conference. Presentation Details: DC Finance's East Coast Family Office & Wealth...

2014-09-15 08:29:14

BETHESDA, Md., Sept. 15, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that Linda F. Powers, CEO, will present at SMi's 3rd Annual Cancer Vaccines Conference being held in Central London on September 15-16, 2014. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO Ms. Powers' presentation will provide updates about the Company's...

2014-09-15 04:21:20

AARHUS, Denmark, September 15, 2014 /PRNewswire/ -- The success rate of assisted reproduction was significantly increased by the use of revolutionary time-lapse technology A study accepted for publication in the renowned scientific journal Fertility & Sterility [http://www.fertstert.org/article/S0015-0282(14)01365-X/abstract ], confirms that a revolutionary and clinically certified technology can substantially increase the success rate in assisted reproduction....

2014-09-12 23:04:25

Medrio brings new Phase I EDC software focus to SCDM San Francisco, CA (PRWEB) September 12, 2014 Medrio, a provider of eClinical Software as a Service (SaaS) and Cloud EDC™ for clinical research, will exhibit at SCDM 2014. After great success at this year’s BIO and DIA conferences, Medrio is excited to showcase its new product suite with an expanded presence at the 20th annual SCDM conference. “SCDM is our third major industry conference in six months, and we are thrilled with...

2014-09-11 23:11:35

Three companies—one European, two American—have teamed up to enable European manufacturers of implantable ophthalmic devices to comply with anticipated regulatory demands for ongoing post-market outcomes data. ZURICH, MADISON, WI, and NEW YORK (PRWEB) September 11, 2014 Three companies—one European, two American—have teamed up to enable European manufacturers of implantable ophthalmic devices to comply with anticipated regulatory demands for ongoing post-market outcomes data. In...

2014-09-11 23:02:43

A research team from the Icahn School of Medicine at Mount Sinai today received a $12 million grant from the National Institutes of Health to create a center that will screen massive data sets for new uses of existing drugs, and confirm them in human cell tests. New York, NY (PRWEB) September 11, 2014 A research team from the Icahn School of Medicine at Mount Sinai today received a $12 million grant from the National Institutes of Health to create a center that will screen massive data...

2014-09-11 08:27:56

MARLBOROUGH, Mass., Sept. 11, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President & CEO, Dr. Geert Cauwenbergh, presented at the Rodman & Renshaw 16(th) Annual Global Investment Conference on Wednesday, September 10, 2014. Dr. Cauwenbergh provided...

2014-09-11 08:27:36

Life sciences service providers leverage PAREXEL's eClinical solutions to simplify drug development for customers through technology partnership initiative BOSTON, Sept. 11, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that clinical technology companies CRF Health and Clinical Ink have joined its Perceptive® Partner Program. Through the program, technology, consulting, reseller and training companies, as...

2014-09-11 04:20:52

DALLAS, September 11, 2014 /PRNewswire/ -- MarketReportsOnline.com adds Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) research report of 194 pages to its store. This research not only provides a comprehensive and thorough knowledge of the latest Chinese regulations for imported medical device registration but also introduces the practical operation on how to comply with the Chinese...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.